A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-06-12
DOI
10.3389/fimmu.2017.00676
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
- (2017) Markus Granzin et al. Frontiers in Immunology
- Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marr
- (2016) Tomasz Czerw et al. CANCER
- Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment
- (2016) Jeremiah L. Oyer et al. CYTOTHERAPY
- Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients
- (2016) Monique M. van Ostaijen-ten Dam et al. JOURNAL OF IMMUNOTHERAPY
- Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
- (2016) Sara Tognarelli et al. Jove-Journal of Visualized Experiments
- Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation
- (2016) Evelyn Ullrich et al. Frontiers in Immunology
- Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma
- (2016) Markus Granzin et al. OncoImmunology
- Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells
- (2015) Gerharda H. Boerman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Multiple effects of IL-21 on human NK cells in ex vivo expansion
- (2015) Qi Li et al. IMMUNOBIOLOGY
- Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21
- (2015) XIAOMEI LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Allogeneic Stem-Cell Transplantation in Patients With NPM1-Mutated Acute Myeloid Leukemia: Results From a Prospective Donor Versus No-Donor Analysis of Patients After Upfront HLA Typing Within the SAL-AML 2003 Trial
- (2015) Christoph Röllig et al. JOURNAL OF CLINICAL ONCOLOGY
- Graft-versus-host disease versus graft-versus-leukemia
- (2015) R. S. Negrin Hematology-American Society of Hematology Education Program
- Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects
- (2015) Kathrin Meinhardt et al. OncoImmunology
- Advances in clinical NK cell studies: Donor selection, manufacturing and quality control
- (2015) U. Koehl et al. OncoImmunology
- Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells
- (2015) Erik Ames et al. OncoImmunology
- Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study
- (2014) Inpyo Choi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Effect of exposure to interleukin-21 at various time points on human natural killer cell culture
- (2014) Dong-Pyo Lim et al. CYTOTHERAPY
- Successful treatment of metastatic rhabdomyosarcoma with radiochemotherapy and allogeneic hematopoietic stem cell transplantation
- (2014) F. Yamazaki et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Functional NK Cell Repertoires Are Maintained through IL-2R and Fas Ligand
- (2014) M. Felices et al. JOURNAL OF IMMUNOLOGY
- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
- (2013) R. Romee et al. BLOOD
- Specific gene delivery to liver sinusoidal and artery endothelial cells
- (2013) T. Abel et al. BLOOD
- Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
- (2013) U Thiel et al. BRITISH JOURNAL OF CANCER
- New prospects on the NKG2D/NKG2DL system for oncology
- (2013) Evelyn Ullrich et al. OncoImmunology
- Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
- (2013) Ashley R. P. Hinson et al. Frontiers in Oncology
- Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
- (2012) M Stern et al. BONE MARROW TRANSPLANTATION
- Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
- (2012) G. Pietra et al. CANCER RESEARCH
- Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A
- (2012) Natasja Nielsen et al. PLoS One
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques
- (2011) T. A. Waldmann et al. BLOOD
- High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation for Metastatic Rhabdomyosarcoma—A Systematic Review
- (2011) Frank Peinemann et al. PLoS One
- IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study
- (2011) Claudia Brehm et al. PLoS One
- NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
- (2010) J. A. Olson et al. BLOOD
- Allogeneic natural killer cells for refractory lymphoma
- (2010) Veronika Bachanova et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
- (2010) Eleni G. Iliopoulou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA
- (2010) Stephan Kloess et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Interactions of Multiple Cytokines Control NK Cell Maturation
- (2010) J. Brady et al. JOURNAL OF IMMUNOLOGY
- Cytokine Secretion Is Distinct from Secretion of Cytotoxic Granules in NK Cells
- (2010) E. Reefman et al. JOURNAL OF IMMUNOLOGY
- IL-2−driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16− Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion
- (2010) Sabine Huenecke et al. JOURNAL OF IMMUNOTHERAPY
- Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN- on activation
- (2010) A. De Maria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-21 augments natural killer effector functions in chronically HIV-infected individuals
- (2009) Natasa Strbo et al. AIDS
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial
- (2009) I. D. Davis et al. CLINICAL CANCER RESEARCH
- Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy
- (2009) M.J. Besser et al. CYTOTHERAPY
- Cooperative Trial CWS-91 for Localized Soft Tissue Sarcoma in Children, Adolescents, and Young Adults
- (2009) Tobias M. Dantonello et al. JOURNAL OF CLINICAL ONCOLOGY
- Graft-versus-host disease
- (2009) James LM Ferrara et al. LANCET
- Comprehensive analysis of NK cell function in whole blood samples
- (2008) Maren Claus et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Natural killer cell–directed therapies: moving from unexpected results to successful strategies
- (2008) Magali Terme et al. NATURE IMMUNOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- Interleukin-21 activates human natural killer cells and modulates their surface receptor expression
- (2007) Kresten Skak et al. IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now